Application Note: Comparison of Biosimilar and Innovator Monoclonal Antibody Rituximab
25 January 2018

This study investigated the monoclonal antibody rituximab and its use in biotherapeutics. The physicochemical and biological characterization of a biosimilar rituximab was carried out using an Agilent 1260 Bio-inert LC system, Bio-columns, and Agilent OpenLAB CDS Match Compare Software tool.